MYC and acute myeloid leukemia: While BET inhibitors function as suppressors of global super enhancer activity13, DHE selectively induces transcription of NR4A nuclear receptors33, which in turn bind to and suppress the activation status of a subset of AML SEs including the AML-selective MYC SE.